Cryptococcosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{CMG}} {{Cryptococcosis}} ==Overview== The standard regimen of treatment in non-AIDS patients intravenous Amphotericin B combined with oral [[flu...") |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
==Medical therapy== | |||
The standard regimen of treatment in non-AIDS patients [[intravenous]] [[Amphotericin B]] combined with [[Wiktionary:oral|oral]] [[flucytosine]]. | The standard regimen of treatment in non-AIDS patients [[intravenous]] [[Amphotericin B]] combined with [[Wiktionary:oral|oral]] [[flucytosine]]. | ||
Revision as of 13:50, 24 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Cryptococcosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryptococcosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Cryptococcosis medical therapy |
|
Risk calculators and risk factors for Cryptococcosis medical therapy |
Overview
Medical therapy
The standard regimen of treatment in non-AIDS patients intravenous Amphotericin B combined with oral flucytosine.
AIDS patients often have a reduced response to Amphotericin B and flucytosine, therefore after initial treatment as above, oral fluconazole can be used.